This study evaluates the feasibility and effect of probiotics on glycemic control in obese adolescents.
Diet-induced intestinal dysbiosis in obese children contributes to the development of type 2 diabetes mellitus (T2D). Probiotic treatment has been proposed to alleviate glycemic dysfunction and prevent/delay development of T2D. The investigators will test probiotics to improve insulin sensitivity and preserve beta cell function in obese children. The probiotic strains are known to improve glycemic control.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
16
900 billion of the following probiotic strains: L. acidophilus DSM24735; L. plantarum DSM24730; L. paracasei DSM24733; L. delbrueckii supsp. bulgaricus DSM24734, S. thermophilus DSM24731, B. longum DSM24736, B. breve DSM24732, and B. infantis DSM24737) maltose (polysaccharide used as food additive, produced from starch), and silicon dioxide (food additive)
maltose (polysaccharide used as food additive, produced from starch), and silicon dioxide (food additive)
Seattle Children's Hosptital
Seattle, Washington, United States
Change in microbiota composition
Microbiome (16S rRNA) analysis, fecal immunoglobulin (Ig)A
Time frame: Baseline and 12 weeks
Change in insulin resistance
Measures of homeostatic model assessment of insulin resistance (HOMA-IR)
Time frame: baseline and 12 weeks
Change in inflammation in blood
measures of high sensitive cardio-reactive protein (hsCRP)
Time frame: baseline and 12 weeks
Change in inflammation in the gut
measure of fecal calprotectin
Time frame: baseline and 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.